Dan Stokely - May 17, 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc. (AMPE)

Role: CFO
Signature: /s/ Daniel Stokely
Stock symbol: AMPE
Transactions as of: May 17, 2021
Transactions value $: -$48,930
Form type: 4
Date filed: 5/19/2021, 05:56 PM
Next filing: Jun 29, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMPE	Common Stock	Options Exercise	$15.1K	+35K	+123.61%	$0.43	63.3K	May 17, 2021	Direct
transaction	AMPE	Common Stock	Sale	-$64K	-35K	-55.28%	$1.83	28.3K	May 18, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMPE	Stock Option (Right to Buy)	Options Exercise	$0	-35K	-11.01%	$0.00	283K	May 17, 2021	Common Stock	35K	$0.43	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Options were previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vested and became exercisable on the date of grant, and the remaining 50% of the stock option award vested and became exercisable on July 31, 2020.